A considerable body of data indicates that the plasma volume, as measured by dye dilution methods, is generally increased in congestive heart failure (1-4). However, recent investigations, utilizing p82 (5, 6) or Cr51 (7) 
A considerable body of data indicates that the plasma volume, as measured by dye dilution methods, is generally increased in congestive heart failure (1) (2) (3) (4) . However, recent investigations, utilizing p82 (5, 6) or Cr51 (7) tagged red cells, indicate that there is little or no increase in total blood volume, plasma volume, or red cell volume in most cases of heart failure.
According to presently accepted concepts, the total body relative cell volume, RBC volume RBC volume + plasma volume' is appreciably lower than the relative cell volume of the blood withdrawn from the large vessels (hematocrit value) (8) (9) (10) (11) (12) (13) (14) (15) (16) , and the ratio between these two is not necessarily constant (17) . It is, therefore, theoretically possible for total erythrocyte volume and venous hematocrit value to remain unchanged in the presence of a significant increase in plasma volume, if the ratio, total body relative cell volume venous hematocrit value decreases. Some such mechanism suggests itself if the aforementioned discrepancies are to be satisfactorily resolved. It was, therefore, considered to be of interest to reinvestigate the status of the blood volume in heart failure by performing simultaneous red cell and plasma volume determinations before and after compensation in a variety of cases of decompensated heart disease.
METHODS
Subjects were hospitalized male patients in whom the diagnoses (Table I ) and the presence of congestive heart failure were verified by at least two observers. Fiftyseven studies were made on 26 was not present in the subjects reported here. Therefore, the weights after restoration of compensation were taken as closest to the "normal" weights of the cardiac subjects and used as reference for all determinations in these cases.
Plasma and erythrocyte volumes
In 22 of the 26 patients studied, compensation was accompanied by a decrease in total blood volume ranging from 3.5 per cent to 23.0 per cent (Table I ). In four of the subjects (Nos. 11, 17, 25, 26) there was an increase in total blood volume following therapy of heart failure. However, in one of these (No. 17, I. S.) clinical improvement was equivocal and, in another (No. 11, L. I.), subsequent relapse into failure was associated with a marked increase in plasma volume which was retained after recompensation. The decrease in blood volume in the 22 patients was chiefly attributable to loss of plasma volume but in most of these, a fall in red cell volume was also noted. The plasma volumes in failure and following compensation were compared with a group of non-cardiac controls on the basis of volume per kilogram body weight ( Figure 1 ). The mean plasma volume for the group of 16 non-cardiac subjects was 42.0 ± 1.19 8 ml. per Kg. which agrees well with other "normal" values obtained in this laboratory and elsewhere. The mean plasma volume for the group of 26 patients in heart failure was 55.6 ± 1.83 ml. per Kg. (Table I , column N, Figure 2 ). In addition, in one instance, a decrease in this ratio was noted following relapse into congestive failure. Furthermore, the mean ratio in 24 patients in congestive heart failure (0.868 ± 0.008) was considerably lower than that of a control group of non-cardiac subjects (0. (9-14, 16, 22) as resulting from a true difference between the relative cell volume of the entire body and that of the large vessels. Others (5, 6, 25) have concluded that the dye methods are in error and that total body relative cell volume does not differ significantly from the venous hematocrit value (5). Although there is no positive data to support the latter concept (5), several arguments derived from indirect evidence must be evaluated.
The origin of the dispute lies in the observation that the plasma soluble substances employed have a space of distribution greater than that of tagged erythrocytes. To conclude from this alone that the former must be distributed extravascularly is to imply that the relative cell volume is the same throughout the body. However, splenic blood, which is rapidly exchangeable with injected Fetagged erythrocytes, has a much higher hematocrit value than blood in the large vessels (26) . In subjects with markedly enlarged spleens, the ratio, total body relative cell volume venous hematocrit value is frequently over 1.00 (27) , a circumstance which is very rarely observed in other subjects. In the normal dog this ratio averages almost 1.00 as determined by Evans Blue and p82 tagged erythro-
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cytes. Yet it cannot be concluded that in this species the relative cell volume is the same in all vessels, for the ratio decreases to 0.90 following LUME splenectomy (28) . Furthermore, there is direct NTS IN HEART evidence that the relative cell volume of minute vessels is lower than that of the large vessels. ) are not in-Krogh (29) (32) . These objections cannot be applied to I13'-labeled serum albumin. Schultz, Hammarsten, Heller, and Ebert (33) demonstrated that the amount of Il3l-labeled albumin appearing in thoracic duct lymph during the period of plasma volume determination does not significantly influence the measurement of plasma volume. In the dog, at least, intravenously administered tagged serum proteins equilibrate more rapidly with thoracic duct lymph than the lymph from the neck or limbs (34) .
The arterial time concentration curves of I'8'-labeled albumin and p32 tagged erythrocytes do not differ significantly between 1 or 1% minutes and 15 minutes, and venous concentrations of I181-labeled albumin do not change significantly between 4 and 20 minutes after injection (16) . Therefore, if the difference between the spaces of distribution of Ill3-labeled albumin and tagged red cells is to be attributed to leakage from the blood stream, this leakage must be completed within a very few minutes. The liver has been suggested as the site of an early leak of T-1824 dye from the blood stream (25) . The possibility of rapid I1S1-labeled albumin accumulation by the liver has previously been evaluated (35) by recording a continuous radioactive assay over the liver from the time of injection. After an initial rapid rise during the first minute, the level of radioactivity remained at a plateau without significant change for the next hour. This observation was confirmed in two cardiac patients of the present series. The possibility of leak into the liver during the first minute was investigated in the rabbit. Following simultaneous injection of P32-tagged rabbit erythrocytes and 1131-labeled human serum albumin into the portal vein, the apparent volumes of distribution in the liver during the first circulation, as determined from hepatic vein samples, did not differ by more than 2 per cent.
The studies of other investigators (26) showed a higher Il31-albumin/Fe-tagged erythrocyte ratio in most organs than in the large blood vessels. Thus, if an early rapid loss of I131-albumin from the blood stream is to explain these findings, this loss must occur throughout the body. It appears unlikely, that within the first few minutes, iodinated albumin exchanges with a diffusely distributed extravascular albumin pool, equivalent in magnitude to approximately 15 per cent of the total plasma albumin. Furthermore, the similar volumes of distribution of bovine serum proteins, T-1824 and pneumococcus polysaccharide S III (36) in animals and of I'31-labeled serum albumin and gamma globulin in humans (37) (Table II) . The mean fall in plasma volume for the entire group would have been calculated as 6 per cent compared to the measured decrease of 12.2 per cent. The results of the present investigation thus suggest why workers using tagged red cells alone failed to find much change in plasma volume following treatment of heart failure. However, regardless of the methods of calculation employed, the values for red cell and plasma volume in congestive heart failure, which have been obtained in the present study, indicate definite increases above normal. The cause of the increased plasma volume in heart failure is not established. Starling (39) believed that a fall in cardiac output leads to reflex vasoconstriction, and that the consequent reduction in intracapillary pressure results in absorption of interstitial fluid into the circulation. Evidence in favor of this view has been reviewed elsewhere (40) . Warren and Stead (41) have postulated that the increase in interstitial fluid tension produced by edema promotes an increase in plasma volume by upsetting the balance of factors regulating net transcapillary fluid exchange. Little support is offered to this concept by the results obtained in the present study, since plasma volumes frequently remained at higher than normal levels following cardiac compensation even in the absence of edema.
The mechanism of the observed decrease in circulating red blood cell volume with compensation is not clear. Waller, Blumgart, and Volk (42) found evidence of red cell destruction in heart failure. However, Watson (43) failed to observe any increase in fecal urobilinogen in cardiac decompensation. Mollison (44) (46) have shown that in human subjects who move from high altitudes to sea level, the red cell iron turnover rate decreases to one-tenth of the initial value, approaching that seen in aplastic anemia. Therefore, the magnitude of the fall in erythrocyte volume observed in this series could be explained by reduced or arrested red cell formation without increased red cell destruction. Hyperplasia of the bone marrow in congestive heart failure with return to normal after compensation has been noted by Ott (47) . Hypoxia of the marrow due to poor blood flow or low arterial 02 tension, secondary to heart failure, is the probable stimulus for the increased erythropoiesis.
SUMMARY AND CONCLUSIONS 1. Red cell and plasma volumes were determined independently in 26 subjects in heart failure and after compensation.
2. Mean values for red blood cell volumes and plasma volumes were elevated above those of control subjects and fell with compensation.
3. The ratio, total body relative cell volume, Thvenous hematocrit value was observed to be decreased in failure and to rise with compensation in the majority of cases. 
